# FDA recall D-297-2013

> **Hospira Inc.** · Class II · drug recall initiated 2013-04-08.

## Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vial, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-4699-30.

## Reason for recall

Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-297-2013
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-04-08
- **Report date:** 2013-05-01
- **Termination date:** 2014-11-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-297-2013

## Citation

> AI Analytics. FDA recall D-297-2013. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-297-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*